“Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device

The Jarvik 2015 Ventricular Assist Device (VAD) (Jarvik Inc, New York, NY) is the first and currently only continuous-flow VAD specifically designed for small children, and it is being evaluated in the so-called Pump for Kids, Infants, and Neonates (PumpKIN) trial. Due to the strict inclusion criter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ASAIO journal (1992) 2021-09, Vol.67 (9), p.1036-1043
Hauptverfasser: Spinner, Joseph A., Tunuguntla, Hari P., Tume, Sebastian C., Elias, Barbara A., Mcmullen, Jason, John, Rija, Choudhry, Swati, Price, Jack F., Denfield, Susan W., Dreyer, William J., Adachi, Iki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1043
container_issue 9
container_start_page 1036
container_title ASAIO journal (1992)
container_volume 67
creator Spinner, Joseph A.
Tunuguntla, Hari P.
Tume, Sebastian C.
Elias, Barbara A.
Mcmullen, Jason
John, Rija
Choudhry, Swati
Price, Jack F.
Denfield, Susan W.
Dreyer, William J.
Adachi, Iki
description The Jarvik 2015 Ventricular Assist Device (VAD) (Jarvik Inc, New York, NY) is the first and currently only continuous-flow VAD specifically designed for small children, and it is being evaluated in the so-called Pump for Kids, Infants, and Neonates (PumpKIN) trial. Due to the strict inclusion criteria of the trial, there have been a group of patients who failed to meet the criteria and therefore received the Jarvik 2015 VAD under the designation of “compassionate use.” This is the same phenomenon seen previously during the Berlin Heart EXCOR trial. While we await the results of the PumpKIN trial, which will report the device performance in a strictly selected population, the compassionate use cases represent actual “real world” experiences. We describe herein our experience of two compassionate use cases. In particular, this report has a special emphasis on the power consumption and hemolysis and inflammatory lab profile of the Jarvik 2015 VAD as hemocompatibility was the primary focus of the developmental and the preclinical phases.
doi_str_mv 10.1097/MAT.0000000000001351
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2479420249</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2479420249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3522-b451b2c60e2d3112ca1093c21a5c6783674a20580d1935570058c6f113f8c24d3</originalsourceid><addsrcrecordid>eNpdUEtPAjEQboxGEP0HxvToZbHttPs4klV8BOMFjbemdLthZWGx3YV444fon-OXWAQfcS4zk3yPmQ-hU0q6lCTRxX1v2CV_ioKge6hNBcRBwuF5389ExAFLaNhCR869eIwAoIeoBcAjEgJvo_569Z5W07lyrqhmqjbr1QdOlTMOVzmuxwbfKbsoJph5Mn4ys9oWuimVxT3PcDW-NItCm2N0kKvSmZNd76DH_tUwvQkGD9e3aW8QaBCMBSMu6IjpkBiWAaVMK_8KaEaV0GEUQxhxxfzRJKMJCBERP-swpxTyWDOeQQedb3XntnptjKvltHDalKWamapxkvEo4Ywwnngo30K1rZyzJpdzW0yVfZOUyE2C0ico_yfoaWc7h2Y0NdkP6TuyX91lVdbGuknZLI2VY6PKevylx3hMAn-EN_FbsFFm8Am5_Hms</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2479420249</pqid></control><display><type>article</type><title>“Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Spinner, Joseph A. ; Tunuguntla, Hari P. ; Tume, Sebastian C. ; Elias, Barbara A. ; Mcmullen, Jason ; John, Rija ; Choudhry, Swati ; Price, Jack F. ; Denfield, Susan W. ; Dreyer, William J. ; Adachi, Iki</creator><creatorcontrib>Spinner, Joseph A. ; Tunuguntla, Hari P. ; Tume, Sebastian C. ; Elias, Barbara A. ; Mcmullen, Jason ; John, Rija ; Choudhry, Swati ; Price, Jack F. ; Denfield, Susan W. ; Dreyer, William J. ; Adachi, Iki</creatorcontrib><description>The Jarvik 2015 Ventricular Assist Device (VAD) (Jarvik Inc, New York, NY) is the first and currently only continuous-flow VAD specifically designed for small children, and it is being evaluated in the so-called Pump for Kids, Infants, and Neonates (PumpKIN) trial. Due to the strict inclusion criteria of the trial, there have been a group of patients who failed to meet the criteria and therefore received the Jarvik 2015 VAD under the designation of “compassionate use.” This is the same phenomenon seen previously during the Berlin Heart EXCOR trial. While we await the results of the PumpKIN trial, which will report the device performance in a strictly selected population, the compassionate use cases represent actual “real world” experiences. We describe herein our experience of two compassionate use cases. In particular, this report has a special emphasis on the power consumption and hemolysis and inflammatory lab profile of the Jarvik 2015 VAD as hemocompatibility was the primary focus of the developmental and the preclinical phases.</description><identifier>ISSN: 1058-2916</identifier><identifier>EISSN: 1538-943X</identifier><identifier>DOI: 10.1097/MAT.0000000000001351</identifier><identifier>PMID: 33470634</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Child ; Clinical Trials as Topic ; Heart Failure - surgery ; Heart-Assist Devices ; Hemolysis ; Humans ; Infant ; Infant, Newborn</subject><ispartof>ASAIO journal (1992), 2021-09, Vol.67 (9), p.1036-1043</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © ASAIO 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3522-b451b2c60e2d3112ca1093c21a5c6783674a20580d1935570058c6f113f8c24d3</citedby><cites>FETCH-LOGICAL-c3522-b451b2c60e2d3112ca1093c21a5c6783674a20580d1935570058c6f113f8c24d3</cites><orcidid>0000-0003-4206-7257 ; 0000-0002-8582-4759 ; 0000-0001-9539-6252 ; 0000-0003-1121-4461</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00002480-202109000-00012$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,778,782,4597,27907,27908,65214</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33470634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spinner, Joseph A.</creatorcontrib><creatorcontrib>Tunuguntla, Hari P.</creatorcontrib><creatorcontrib>Tume, Sebastian C.</creatorcontrib><creatorcontrib>Elias, Barbara A.</creatorcontrib><creatorcontrib>Mcmullen, Jason</creatorcontrib><creatorcontrib>John, Rija</creatorcontrib><creatorcontrib>Choudhry, Swati</creatorcontrib><creatorcontrib>Price, Jack F.</creatorcontrib><creatorcontrib>Denfield, Susan W.</creatorcontrib><creatorcontrib>Dreyer, William J.</creatorcontrib><creatorcontrib>Adachi, Iki</creatorcontrib><title>“Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device</title><title>ASAIO journal (1992)</title><addtitle>ASAIO J</addtitle><description>The Jarvik 2015 Ventricular Assist Device (VAD) (Jarvik Inc, New York, NY) is the first and currently only continuous-flow VAD specifically designed for small children, and it is being evaluated in the so-called Pump for Kids, Infants, and Neonates (PumpKIN) trial. Due to the strict inclusion criteria of the trial, there have been a group of patients who failed to meet the criteria and therefore received the Jarvik 2015 VAD under the designation of “compassionate use.” This is the same phenomenon seen previously during the Berlin Heart EXCOR trial. While we await the results of the PumpKIN trial, which will report the device performance in a strictly selected population, the compassionate use cases represent actual “real world” experiences. We describe herein our experience of two compassionate use cases. In particular, this report has a special emphasis on the power consumption and hemolysis and inflammatory lab profile of the Jarvik 2015 VAD as hemocompatibility was the primary focus of the developmental and the preclinical phases.</description><subject>Child</subject><subject>Clinical Trials as Topic</subject><subject>Heart Failure - surgery</subject><subject>Heart-Assist Devices</subject><subject>Hemolysis</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><issn>1058-2916</issn><issn>1538-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUEtPAjEQboxGEP0HxvToZbHttPs4klV8BOMFjbemdLthZWGx3YV444fon-OXWAQfcS4zk3yPmQ-hU0q6lCTRxX1v2CV_ioKge6hNBcRBwuF5389ExAFLaNhCR869eIwAoIeoBcAjEgJvo_569Z5W07lyrqhmqjbr1QdOlTMOVzmuxwbfKbsoJph5Mn4ys9oWuimVxT3PcDW-NItCm2N0kKvSmZNd76DH_tUwvQkGD9e3aW8QaBCMBSMu6IjpkBiWAaVMK_8KaEaV0GEUQxhxxfzRJKMJCBERP-swpxTyWDOeQQedb3XntnptjKvltHDalKWamapxkvEo4Ywwnngo30K1rZyzJpdzW0yVfZOUyE2C0ico_yfoaWc7h2Y0NdkP6TuyX91lVdbGuknZLI2VY6PKevylx3hMAn-EN_FbsFFm8Am5_Hms</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Spinner, Joseph A.</creator><creator>Tunuguntla, Hari P.</creator><creator>Tume, Sebastian C.</creator><creator>Elias, Barbara A.</creator><creator>Mcmullen, Jason</creator><creator>John, Rija</creator><creator>Choudhry, Swati</creator><creator>Price, Jack F.</creator><creator>Denfield, Susan W.</creator><creator>Dreyer, William J.</creator><creator>Adachi, Iki</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4206-7257</orcidid><orcidid>https://orcid.org/0000-0002-8582-4759</orcidid><orcidid>https://orcid.org/0000-0001-9539-6252</orcidid><orcidid>https://orcid.org/0000-0003-1121-4461</orcidid></search><sort><creationdate>20210901</creationdate><title>“Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device</title><author>Spinner, Joseph A. ; Tunuguntla, Hari P. ; Tume, Sebastian C. ; Elias, Barbara A. ; Mcmullen, Jason ; John, Rija ; Choudhry, Swati ; Price, Jack F. ; Denfield, Susan W. ; Dreyer, William J. ; Adachi, Iki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3522-b451b2c60e2d3112ca1093c21a5c6783674a20580d1935570058c6f113f8c24d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Child</topic><topic>Clinical Trials as Topic</topic><topic>Heart Failure - surgery</topic><topic>Heart-Assist Devices</topic><topic>Hemolysis</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spinner, Joseph A.</creatorcontrib><creatorcontrib>Tunuguntla, Hari P.</creatorcontrib><creatorcontrib>Tume, Sebastian C.</creatorcontrib><creatorcontrib>Elias, Barbara A.</creatorcontrib><creatorcontrib>Mcmullen, Jason</creatorcontrib><creatorcontrib>John, Rija</creatorcontrib><creatorcontrib>Choudhry, Swati</creatorcontrib><creatorcontrib>Price, Jack F.</creatorcontrib><creatorcontrib>Denfield, Susan W.</creatorcontrib><creatorcontrib>Dreyer, William J.</creatorcontrib><creatorcontrib>Adachi, Iki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ASAIO journal (1992)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spinner, Joseph A.</au><au>Tunuguntla, Hari P.</au><au>Tume, Sebastian C.</au><au>Elias, Barbara A.</au><au>Mcmullen, Jason</au><au>John, Rija</au><au>Choudhry, Swati</au><au>Price, Jack F.</au><au>Denfield, Susan W.</au><au>Dreyer, William J.</au><au>Adachi, Iki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device</atitle><jtitle>ASAIO journal (1992)</jtitle><addtitle>ASAIO J</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>67</volume><issue>9</issue><spage>1036</spage><epage>1043</epage><pages>1036-1043</pages><issn>1058-2916</issn><eissn>1538-943X</eissn><abstract>The Jarvik 2015 Ventricular Assist Device (VAD) (Jarvik Inc, New York, NY) is the first and currently only continuous-flow VAD specifically designed for small children, and it is being evaluated in the so-called Pump for Kids, Infants, and Neonates (PumpKIN) trial. Due to the strict inclusion criteria of the trial, there have been a group of patients who failed to meet the criteria and therefore received the Jarvik 2015 VAD under the designation of “compassionate use.” This is the same phenomenon seen previously during the Berlin Heart EXCOR trial. While we await the results of the PumpKIN trial, which will report the device performance in a strictly selected population, the compassionate use cases represent actual “real world” experiences. We describe herein our experience of two compassionate use cases. In particular, this report has a special emphasis on the power consumption and hemolysis and inflammatory lab profile of the Jarvik 2015 VAD as hemocompatibility was the primary focus of the developmental and the preclinical phases.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>33470634</pmid><doi>10.1097/MAT.0000000000001351</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4206-7257</orcidid><orcidid>https://orcid.org/0000-0002-8582-4759</orcidid><orcidid>https://orcid.org/0000-0001-9539-6252</orcidid><orcidid>https://orcid.org/0000-0003-1121-4461</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1058-2916
ispartof ASAIO journal (1992), 2021-09, Vol.67 (9), p.1036-1043
issn 1058-2916
1538-943X
language eng
recordid cdi_proquest_miscellaneous_2479420249
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Child
Clinical Trials as Topic
Heart Failure - surgery
Heart-Assist Devices
Hemolysis
Humans
Infant
Infant, Newborn
title “Compassionate” Cases of the Jarvik 2015 Ventricular Assist Device
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A21%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CCompassionate%E2%80%9D%20Cases%20of%20the%20Jarvik%202015%20Ventricular%20Assist%20Device&rft.jtitle=ASAIO%20journal%20(1992)&rft.au=Spinner,%20Joseph%20A.&rft.date=2021-09-01&rft.volume=67&rft.issue=9&rft.spage=1036&rft.epage=1043&rft.pages=1036-1043&rft.issn=1058-2916&rft.eissn=1538-943X&rft_id=info:doi/10.1097/MAT.0000000000001351&rft_dat=%3Cproquest_cross%3E2479420249%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2479420249&rft_id=info:pmid/33470634&rfr_iscdi=true